Pharmacy-Based Sale of Chlamydia Test Kits Is Effective

Share this content:
Pharmacy-Based Sale of Chlamydia Test Kits Is Effective
Pharmacy-Based Sale of Chlamydia Test Kits Is Effective

FRIDAY, Dec. 30, 2016 (HealthDay News) -- It is feasible to sell chlamydia test kits through pharmacies and use existing health infrastructure to follow up on results and manage clients, according to a pilot study published online Dec. 23 in the Journal of Pharmacy Practice and Research.

Joseph Debattista, Ph.D., from the Metro North Hospital & Health Service in Brisbane, Australia, and colleagues assessed postal specimen kits for chlamydia testing. Kits were sold at a minimal price at 18 community pharmacies. Samples, collected via UriSwab, were mailed to a centralized service for processing, and results were returned directly to clients.

The researchers found that over a nine-month period, 32.7 percent of 333 available test kits were sold. Of the 109 sold tests, 43 specimens were returned for processing. Of the returned samples, seven produced reactive results, 34 produced non-reactive results, and one was invalid.

"Despite a low specimen return rate (12.9 percent of total kits available; 39.4 percent of kits sold), a high reactivity rate (16.3 percent) for chlamydia was identified among those persons purchasing a kit and returning a sample, suggesting that the pharmacy program had been effectively targeted," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »